L'OREAL UV Absorbing System with Oil for Preventing Material Aggregation
Summary
The USPTO published L'OREAL's patent application (US20260096963A1) for a UV absorbing composition combining physical UV-attenuating materials with oils to inhibit particle aggregation. The invention targets improved stability in sunscreen and cosmetic formulations. The application was filed on October 4, 2024, under application number 18906290.
What changed
The USPTO published L'OREAL's patent application for a UV absorbing system combining physical UV-attenuating materials with oils designed to prevent aggregation of the UV-attenuating particles. The composition aims to improve stability and performance in sunscreen and cosmetic applications.
Competitors in the cosmetics and personal care industry should review the published technical details to assess freedom-to-operate considerations and monitor for eventual patent grant. The application represents L'OREAL's intellectual property position in UV protection formulation technology.
What to do next
- Monitor for updates on patent grant status
Archived snapshot
Apr 9, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
Compositions Containing a UV-Absorbing System Including Physical UV-Attenuating Material and Oil For Inhibiting Physical UV-Attenuating Material Aggregation
Application US20260096963A1 Kind: A1 Apr 09, 2026
Assignee
L'OREAL
Inventors
FRÉDÉRIC SIMONET, Amélie Friot
Abstract
The present disclosure relates to compositions including a UV absorbing system including at least one physical ultraviolet (UV)-attenuating material and at least one oil for inhibiting physical ultraviolet (UV)-attenuating material aggregation, as well as to methods of making and using such compositions.
CPC Classifications
A61K 8/27 A61Q 17/04 A61K 2800/30 A61K 2800/413 A61K 2800/62
Filing Date
2024-10-04
Application No.
18906290
Related changes
Get daily alerts for USPTO Patent Applications - Pharma (A61K)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The plain-English summary, classification, and "what to do next" steps are AI-generated from the original text. Cite the source document, not the AI analysis.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Applications - Pharma (A61K) publishes new changes.